PDF herunterladen
Semin Reprod Med 2015; 33(03): 213-219
DOI: 10.1055/s-0035-1552920
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pregnancy in Polycystic Ovary Syndrome I: Lessons from a Pragmatic Explanatory with Repository Clinical Trial

Richard S. Legro
1   Department of Obstetrics and Gynecology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Juni 2015 (online)

    Lizenzen und Reprints

Abstract

This article reports results from a multicenter pragmatic study, with explanatory components and also with a repository, the Pregnancy in Polycystic Ovary Syndrome I study (Clinicaltrials.gov: NCT00068861), which we label with the acronym PERCT. This was a study conceived and conducted by the Steering Committee of the Reproductive Medicine Network. We discuss the publication structure from the study, including concept, protocol baseline, primary and secondary outcome papers, as well as ancillary papers related to studies conducted using biosamples from the study repository. We demonstrate that the primary outcome paper remains far and away the most impactful publication from this study. However, we note also that other related publications, including the baseline paper and some papers related to secondary hypotheses, such as prediction models, can still be relatively impactful. However, the most impactful ancillary publications arose from utilizing specimens in the repository to test post hoc hypotheses. Therefore, establishing a repository of serum and DNA samples, and potentially other biological specimens (i.e., semen, urine, biome samples, etc.) and making these specimens and data available to investigators may provide further meaningful productivity to a large pragmatic multicenter trial known here as PERCT.

Keywords

infertility - hyperandrogenism - randomized clinical trial - insulin resistance
 

  • References

  • 1 Roland M, Torgerson DJ. What are pragmatic trials?. BMJ 1998; 316 (7127) 285
    CrossrefPubMedSuche in Google Scholar
  • 2 Brousseau ME, Schaefer EJ, Wolfe ML , et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 2004; 350 (15) 1505-1515
    CrossrefPubMedSuche in Google Scholar
  • 3 Barter PJ, Caulfield M, Eriksson M , et al; ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357 (21) 2109-2122
    CrossrefPubMedSuche in Google Scholar
  • 4 Legro RS, Barnhart HX, Schlaff WD , et al; Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356 (6) 551-566
    CrossrefPubMedSuche in Google Scholar
  • 5 Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, , eds. Polycystic Ovary Syndrome. Boston, MA: Blackwell Scientific; 1992: 377-384
    Suche in Google Scholar
  • 6 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19 (1) 41-47
    CrossrefPubMedSuche in Google Scholar
  • 7 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (1) 19-25
    PubMedSuche in Google Scholar
  • 8 Casson PR, Krawetz SA, Diamond MP , et al. Proactively establishing a biologic specimens repository for large clinical trials: an idea whose time has come. Syst Biol Reprod Med 2011; 57: 217-221
    CrossrefPubMedSuche in Google Scholar
  • 9 Krawetz SA, Casson PR, Diamond MP , et al. Establishing a biologic specimens repository for reproductive clinical trials: technical aspects. Syst Biol Reprod Med 2011; 57: 222-227
    CrossrefPubMedSuche in Google Scholar
  • 10 Legro RS. In defense of publishing baseline data from clinical trials. Fertil Steril 2015; 103 (4) 902-903
    CrossrefPubMedSuche in Google Scholar
  • 11 Rausch ME, Legro RS, Barnhart HX , et al; Reproductive Medicine Network. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94 (9) 3458-3466
    CrossrefPubMedSuche in Google Scholar
  • 12 Diamond MP, Kruger M, Santoro N , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol 2012; 119 (5) 902-908
    CrossrefPubMedSuche in Google Scholar
  • 13 Hurst BS, Hickman JM, Matthews ML, Usadi RS, Marshburn PB. Novel clomiphene “stair-step” protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obstet Gynecol 2009; 200: 510.e1-510.e4
    CrossrefPubMedSuche in Google Scholar
  • 14 Legro RS, Barnhart HX, Schlaff WD , et al; Reproductive Medicine Network. Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J Clin Endocrinol Metab 2008; 93 (3) 792-800
    CrossrefPubMedSuche in Google Scholar
  • 15 López-Bermejo A, Díaz M, Morán E, de Zegher F, Ibáñez L. A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess. Diabetes Care 2010; 33 (7) 1544-1548
    CrossrefPubMedSuche in Google Scholar
  • 16 Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92 (2) 405-413
    CrossrefPubMedSuche in Google Scholar
  • 17 Legro RS, Schlaff WD, Diamond MP , et al; Reproductive Medicine Network. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 2010; 95 (12) 5305-5313
    CrossrefPubMedSuche in Google Scholar
  • 18 Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 2013; 98 (10) 3971-3973
    CrossrefPubMedSuche in Google Scholar
  • 19 Wierman ME, Auchus RJ, Haisenleder DJ , et al. Editorial: the new instructions to authors for the reporting of steroid hormone measurements. J Clin Endocrinol Metab 2014; 99 (12) 4375
    CrossrefPubMedSuche in Google Scholar
  • 20 Diamond MP, Legro RS, Coutifaris C , et al. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics. Fertil Steril 2015; 103: 962-973.e4
    CrossrefPubMedSuche in Google Scholar
  • 21 Legro RS, Myers ER, Barnhart HX , et al; Reproductive Medicine Network. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006; 86 (4) 914-933
    CrossrefPubMedSuche in Google Scholar
  • 22 Legro RS, Chen G, Kunselman AR , et al; Reproductive Medicine Network. Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. Hum Reprod 2014; 29 (12) 2680-2686
    CrossrefPubMedSuche in Google Scholar
  • 23 Richard S, Legro MD, Robert G , et al; the NICHD Reproductive Medicine Network. The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multi-center randomized clinical trial. Fertil Steril 2014; 101 (1) 258-269
    CrossrefPubMedSuche in Google Scholar
  • 24 Legro RS, Myers E. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?. Hum Reprod 2004; 19 (8) 1697-1704
    CrossrefPubMedSuche in Google Scholar
  • 25 Myers ER, Silva SG, Hafley G, Kunselman AR, Nestler JE, Legro RS ; National Institute of Child Health and Human Development Reproductive Medicine Network. Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemp Clin Trials 2005; 26 (3) 271-280
    CrossrefPubMedSuche in Google Scholar
  • 26 McGovern PG, Legro RS, Myers ER , et al; National Institutes for Child Health and Human Development-Reproductive Medicine Network. Utility of screening for other causes of infertility in women with “known” polycystic ovary syndrome. Fertil Steril 2007; 87 (2) 442-444
    CrossrefPubMedSuche in Google Scholar
  • 27 Cataldo NA, Barnhart HX, Legro RS , et al; Reproductive Medicine Network. Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93 (8) 3124-3127
    CrossrefPubMedSuche in Google Scholar
  • 28 McGovern PG, Carson SA, Barnhart HX , et al; National Institute of Child Health and Human Development-Reproductive Medicine Network. Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial. Fertil Steril 2008; 90 (4) 1283-1286
    CrossrefPubMedSuche in Google Scholar
  • 29 Pagidas K, Carson SA, McGovern PG , et al; National Institute of Child Health and Human Development-Reproductive Medicine Network. Body mass index and intercourse compliance. Fertil Steril 2010; 94 (4) 1447-1450
    CrossrefPubMedSuche in Google Scholar
  • 30 Pagidas K, Carson SA, McGovern PG , et al; National Institute of Child Health and Human Development-Reproductive Medicine Network. Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) trial. Fertil Steril 2010; 94 (4) 1444-1446
    CrossrefPubMedSuche in Google Scholar
  • 31 Aubuchon M, Kunselman AR, Schlaff WD , et al; Reproductive Medicine Network. Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96 (10) E1645-E1649
    CrossrefPubMedSuche in Google Scholar
  • 32 Zhang H, Legro RS, Zhang J , et al; Reproductive Medicine Network. Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod 2010; 25 (10) 2612-2621
    CrossrefPubMedSuche in Google Scholar
  • 33 Roth LW, Huang H, Legro RS , et al; Reproductive Medicine Network. Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. Obstet Gynecol 2012; 119 (6) 1151-1156
    CrossrefPubMedSuche in Google Scholar
  • 34 Schlaff WD, Zhang H, Diamond MP , et al; Reproductive Medicine Network. Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies. Fertil Steril 2011; 96 (1) 15-18
    CrossrefPubMedSuche in Google Scholar
  • 35 Jones MR, Chua AK, Mengesha EA , et al; Reproductive Medicine Network. Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids 2012; 77 (4) 317-322
    CrossrefPubMedSuche in Google Scholar